Numans Health Food Holdings Company Limited (Stock Code: 02530, abbreviated “NUMANS”) announced a forthcoming shift in compliance advisers. The company and Caitong International Capital Co., Limited mutually agreed to terminate their compliance adviser agreement dated 13 Jan 2024, with the termination taking effect on 9 Mar 2026 due to a fee-adjustment disagreement.

Effective 10 Mar 2026, Innovax Capital Limited will assume the role of compliance adviser in accordance with Rule 3A.27 of the Listing Rules. Innovax is licensed to conduct Type 1 (dealing in securities) and Type 6 (advising on corporate finance) regulated activities under the Securities and Futures Ordinance (Cap. 571, Hong Kong).

The engagement with Innovax will continue until the earlier of: 1) NUMANS’ compliance with Rule 13.46 for its first full-year financial results post-listing (financial year ending 31 Dec 2026), or 2) termination of the compliance adviser agreement under its specified terms.

Both the board of directors and Caitong confirmed that, as of the announcement date, no other matters related to the termination require attention from shareholders or the Stock Exchange.

Chairman Wang Ping signed the announcement on behalf of the board on 9 Mar 2026. Current board composition comprises two executive directors (Wang Ping, Cui Juan), one non-executive director (Chan Hok Leung), and three independent non-executive directors (Yim Wing Yee, Lau Kwok Fai Patrick, Yu Tsz Ngo).